US FDA says Lilly's weight-loss drug shortage is resolved
The U.S. Food and Drug Administration on Thursday found that there was no longer a shortage of Eli Lilly's blockbuster weight ...
Bloomberg L.P.2h
Lilly Weight-Loss Drug Shortage in US Has Ended, FDA Says
Eli Lilly & Co.’s weight-loss and diabetes drugs Mounjaro and Zepbound are no longer in short supply in the US, which means ...
US FDA says Lilly's weight-loss drug shortage resolved
The U.S. Food and Drug Administration said on Thursday that Eli Lilly's weight-loss drug shortage has been resolved, ...
Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug
Merck gets exclusive global rights to develop, manufacture and commercialize GLP-1 receptor agonist, HS-10535, from Hansoh ...
News Highlights: Top Company News of the Day - Wednesday at 9 PM ET
Memory-chip maker swung to a profit and posted higher revenue in its fiscal first quarter, though shares fell after the company's outlook missed estimates. CVS ignored substantial evidence from ...
UnitedHealthcare Sued by Dozens of Schools Over Price of Insulin
Lawsuits filed in New Jersey are part of hundreds of complaints against UnitedHealthcare, PBMs, and pharmaceutical giants ...
BioPharma Dive16h
Zepbound, Mounjaro shortages are resolved, FDA confirms
The Food and Drug Administration on Thursday reaffirmed its assessment that Mounjaro and Zepbound, popular drugs for diabetes and obesity ... Hers Health fell by about 10% in Thursday trading on news ...